001065.KS
JW Pharmaceutical Corporation
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 22,650.00
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 6.17x
- P/E 2027E
- 5.69x
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 5.40x
- PEG TTM
- 0.21x
- Price / book
- 1.33x
- Price / sales
- 0.67x
- Price / cash flow
- 4.07x
Enterprise value
- Enterprise value
- KRW 562.1B
- EV / sales
- 0.69x
- EV / EBITDA
- 4.47x
- EV / EBIT
- 4.91x
- Market cap
- KRW 546.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026